Multinationals are increasingly turning to emerging economies in Asia as growth in their core markets in the West stagnate or even decline. However, growing in Asia is complex and challenging, requiring multinationals to develop extensive local market knowledge, build broad distribution network and establish deep stakeholder relationships. All these challenges are difficult to overcome quickly and efficiently through organic strategies. It comes as no surprise then, to see Asia emerged as a hotbed for Healthcare M&A activities accounting for more than 20% of global deals.

Clearstate, an Economist Intelligence Unit Healthcare business, has responded to the growth in M&A by creating a Medtech Series M&A intelligence offering. This identifies target potentials in Medtech that are differentiated by asset class, sector and therapy area. We run a thorough scan that allows us to uncover “hidden” gems that otherwise may remain unnoticed in Asia’s fragmented and fast-moving environment.

Download the brochure on this new service by completing the form opposite which can be accessed at the link below